Perrigo | PRGO - Current Liabilities



Perrigo reported $1.13B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
AbbVie USD 36.4B 2.35B Mar/2025
Abbott USD 13.44B 435M Jun/2025
Bayer EUR 29.78B 1.82B Jun/2025
Bristol-Myers Squibb USD 27.53B 3.46B Jun/2025
Corcept Therapeutics USD 144.66M 1.6M Jun/2025
Dr.Reddys Laboratories INR 142.59B 12.25B Jun/2025
Eli Lilly USD 39.02B 8.95B Jun/2025
J&J USD 56.9B 6.58B Mar/2025
Merck USD 26.04B 863M Jun/2025
Nestle CHF 46.82B 3.96B Jun/2025
Pacira USD 313.16M 1.57M Jun/2025
Perrigo USD 1.13B 52.3M Jun/2025
Pfizer USD 37.73B 1.27B Jun/2025
Prestige Brands USD 109.67M 3.04M Jun/2025
Reckitt Benckiser GBP 7.94B 901M Dec/2024
Sanofi 29.06B 3.16B Jun/2025
Supernus Pharmaceuticals USD 286.36M 4.59M Jun/2025
Teva Pharmaceutical Industries USD 11.86B 704M Jun/2025
Xeris Pharmaceuticals USD 95.17M 5.27M Jun/2025
Zoetis USD 3.37B 19M Jun/2025